Diabetes Treatments | Novo Nordisk U.S.
View a list of Novo Nordisk's current diabetes products along with prescribing information and links to their individual product sites for patients and physicians.
Diabetes Treatments & Insulin Pen Devices | NovoCare®
Find information about Novo Nordisk medications and devices used to treat diabetes, including insulin and non-insulin medicines.
Help With Insulin Costs & Diabetes Prescription - NovoCare
Novo Nordisk is working to ensure you have the medicine you need no matter your situation. Our programs and offers may help reduce the cost of your insulin or provide it at no cost, depending on your situation.
Novo Nordisk Patient Assistance Program (PAP) - NovoCare
Apply for the Novo Nordisk Patient Assistance Program (PAP) to see if you qualify to receive your Novo Nordisk diabetes medicine at no cost.
Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL is a combination of insulin degludec and liraglutide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. • Xultophy ® 100/3.6 is not recommended as first-line therapy
Different Types of Insulin for Type 2 Diabetes - NovoCare
Learn about the different types of insulin, including short-acting, intermediate-acting, and premixed. Find out how each type works to treat type 2 diabetes.
Diabetes Product Education for Professionals - novoMEDLINK
Explore the extensive Novo Nordisk library of diabetes treatment education for health care professionals. Learn more about our product portfolio, including pharmacokinetics, mechanisms of action and study results.
Tresiba® Official Physician Site | Tresiba® (insulin degludec ...
Learn about Tresiba® (insulin degludec), a once-daily, long-acting basal insulin for patients over 1 year of age with type 1 or type 2 diabetes. Read Important Safety & Prescribing Info.
News Details - Novo Nordisk
Bagsværd, Denmark, 3 October 2022 – Novo Nordisk today announced headline results from the ONWARDS 5 phase 3a trial with once-weekly insulin icodec in people with type 2 diabetes.
About Type 1 and Type 2 Diabetes | Novo Nordisk U.S.
Type 1 diabetes is defined as when your pancreas does not make or makes very little insulin. It is thought to be caused by an autoimmune reaction that destroys the cells in the pancreas that make insulin, called beta cells.